tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
449 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$12.31
$612.00M
6.86%
9 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$2.83
$304.90M
-86.94%
10 Buy
7 Hold
1 Sell
Moderate Buy
Dianthus Therapeutics
$17.44
$560.87M
-29.90%
5 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$9.49
$731.55M
24.21%
7 Buy
0 Hold
0 Sell
Strong Buy
LENZ Therapeutics
$30.03
$845.23M
63.43%
7 Buy
0 Hold
0 Sell
Strong Buy
GH Research
$11.84
$734.41M
2.93%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
12.15
0.41
3.49%
RCKT
Rocket Pharmaceuticals
2.70
-19.78
-87.99%
DNTH
Dianthus Therapeutics
17.44
-8.09
-31.69%
REPL
Replimune Group
9.49
0.99
11.65%
LENZ
LENZ Therapeutics
29.94
11.53
62.63%
GHRS
GH Research
12.31
0.51
4.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis